These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 19533440

  • 1. Successful heparin desensitization after anaphylactic shock due to heparin.
    Altintaş ND, Aybar Türkoğlu M, Bozkurt B, Topeli Iskit A, Karakaya G, Kalyoncu AF.
    Tuberk Toraks; 2009; 57(1):68-72. PubMed ID: 19533440
    [Abstract] [Full Text] [Related]

  • 2. [Present opinions concerning the administration of low molecular weight heparins in hemodialysis patients].
    Drozdz M, Kowalczyk-Michałek M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2005; 62(4):257-9. PubMed ID: 16229247
    [Abstract] [Full Text] [Related]

  • 3. Heparin-induced recurrent anaphylaxis.
    Berkun Y, Haviv YS, Schwartz LB, Shalit M.
    Clin Exp Allergy; 2004 Dec; 34(12):1916-8. PubMed ID: 15663568
    [Abstract] [Full Text] [Related]

  • 4. Induction of tolerance to warfarin after anaphylaxis with a desensitization protocol.
    Jameson T, Siri D.
    Cardiology; 2010 Dec; 115(3):174-5. PubMed ID: 20090323
    [Abstract] [Full Text] [Related]

  • 5. [How safe is our treatment with heparins? (interview by Maria Weiss)].
    Lindhoff-Last E.
    MMW Fortschr Med; 2008 May 29; 150(22):7. PubMed ID: 18700259
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
    Nutescu EA, Spinler SA, Wittkowsky A, Dager WE.
    Ann Pharmacother; 2009 Jun 29; 43(6):1064-83. PubMed ID: 19458109
    [Abstract] [Full Text] [Related]

  • 8. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH.
    Thromb Haemost; 2005 Dec 29; 94(6):1265-9. PubMed ID: 16411404
    [Abstract] [Full Text] [Related]

  • 9. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [Abstract] [Full Text] [Related]

  • 10. Management and successful desensitization in methotrexate-induced anaphylaxis.
    Bouchireb K, Dodille A, Ponvert C, Gouraud F, Dubrel M, Brugières L.
    Pediatr Blood Cancer; 2009 Feb 01; 52(2):295-7. PubMed ID: 18855892
    [Abstract] [Full Text] [Related]

  • 11. AANA Journal course: update for nurse anesthetists--low molecular weight heparin: pharmacology and regional anesthetic implications.
    Thames BC, Allen DO.
    AANA J; 2000 Aug 01; 68(4):357-64. PubMed ID: 11125607
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P, Simon N, Opris A, Faure V, Lorec-Penet AM, Portugal H, Dussol B, Berland Y.
    Am J Kidney Dis; 2008 May 01; 51(5):789-95. PubMed ID: 18436089
    [Abstract] [Full Text] [Related]

  • 13. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH, Weger W, Reiter H, Arbab E, Kränke B, Aberer W.
    Br J Dermatol; 2007 Sep 01; 157(3):514-7. PubMed ID: 17573880
    [Abstract] [Full Text] [Related]

  • 14. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A.
    Br J Haematol; 2005 Feb 01; 128(3):389-92. PubMed ID: 15667543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Continuous intravenous infusion of a low-molecular-weight heparin during allogenic haematopoietic stem-cell transplantation.
    Boeras A, Lambert C, Ferrant A, van den Neste E, Hermans C.
    Blood Coagul Fibrinolysis; 2008 Oct 01; 19(7):735-7. PubMed ID: 18832921
    [Abstract] [Full Text] [Related]

  • 20. Severe anaphylactic reaction in a haemodialysis patient after administration of reviparin.
    Basic-Jukic N, Kes P.
    Nephrol Dial Transplant; 2004 Apr 01; 19(4):1021-2. PubMed ID: 15031381
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.